Skip to main content

Table 6 Change in the use of antibiotics

From: Effectiveness, safety and tolerability of a complex homeopathic medicinal product in the prevention of recurrent acute upper respiratory tract infections in children: a multicenter, open, comparative, randomized, controlled clinical trial

Antibiotics use for URTI and ENT diseases

Baseline (12 months prior to study start)

3rd FU Visit (months 1-3 of post-treatment)

Termination Visit (months 4-6 of post-treatment)

CalSuli-4-02 group N = 99

Control group N = 101

CalSuli-4-02 group N = 99

Control group N = 101

CalSuli-4-02 group N = 99

Control group N = 101

N

%

N

%

N

%

N

%

N

%

N

%

Always

18

18.2

11

10.9

2

2.0

8

7.9

2

2.0

5

5.0

Sometimes

34

34.3

42

41.6

7

7.1

12

11.9

5

5.1

12

11.9

Seldom

27

27.3

35

34.7

14

14.1

12

11.9

8

8.1

4

4.0

Never

20

20.2

12

11.9

65

65.7

53

52.5

65

65.7

60

59.4

Missing

0

0.0

1

1.0

11

11.1

16

15.8

19

19.2

20

19.8

  1. FU follow-up, ITT intention-to-treat analysis